Cynthia M Mojica1, Bonnie Lind2, Yifan Gu2, Gloria D Coronado3, Melinda M Davis4. 1. College of Public Health and Human Sciences, Oregon State University, Corvallis, Oregon. Electronic address: cynthia.mojica@oregonstate.edu. 2. Center for Health Systems Effectiveness, Oregon Health & Science University, Portland, Oregon. 3. Kaiser Permanente Center for Health Research, Portland, Oregon. 4. Department of Family Medicine, School of Public Health, Oregon Health & Science University, Portland, Oregon; 5Oregon Rural Practice-based Research Network, Oregon Health & Science University, Portland, Oregon.
Abstract
INTRODUCTION: This study examines individual- and practice-level predictors of screening modality among 1,484 Medicaid enrollees who initiated colorectal cancer screening (fecal immunochemical test/fecal occult blood tests or colonoscopy) within a year of turning age 50 years. Understanding screening modality patterns for patients and health systems can help optimize colorectal cancer screening initiatives that will lead to high screening completion rates. METHODS: Multivariable logistic regression was conducted in 2019 to analyze Medicaid claims data (January 2013-June 2015) to explore predictors of colonoscopy screening (versus fecal testing). RESULTS: Overall, 64% of enrollees received a colonoscopy and 36% received a fecal immunochemical test/fecal occult blood test. Male (OR=1.21, 95% CI=1.08, 1.37) compared with female enrollees and those with 4-6 (OR=1.57, 95% CI=1.15, 2.15), 7-10 (OR=2.23, 95% CI=1.64, 3.03), and ≥11 (OR=1.79, 95% CI=1.22, 2.65) primary care visits compared with 0-3 visits had higher odds of colonoscopy screening. Non-White, non-Hispanic enrollees (OR=0.71, 95% CI=0.58, 0.87) compared with White, non-Hispanics Whites had lower odds of colonoscopy screening. Practices with an endoscopy facility within their ZIP code (OR=1.50, 95% CI=1.08, 2.08) compared with practices without a nearby endoscopy facility had higher odds of colonoscopy screening. CONCLUSIONS: Among newly age-eligible Medicaid enrollees who received colorectal cancer screening, non-White, non-Hispanic individuals were less likely and male enrollees and those with ≥4 primary care visits were more likely to undergo colonoscopy versus fecal immunochemical test/fecal occult blood test. Colonoscopy also was the more common modality among adults whose primary care clinic had an endoscopy facility in the same ZIP code. Future research is needed to fully understand patient, provider, and practice preferences regarding screening modality.
INTRODUCTION: This study examines individual- and practice-level predictors of screening modality among 1,484 Medicaid enrollees who initiated colorectal cancer screening (fecal immunochemical test/fecal occult blood tests or colonoscopy) within a year of turning age 50 years. Understanding screening modality patterns for patients and health systems can help optimize colorectal cancer screening initiatives that will lead to high screening completion rates. METHODS: Multivariable logistic regression was conducted in 2019 to analyze Medicaid claims data (January 2013-June 2015) to explore predictors of colonoscopy screening (versus fecal testing). RESULTS: Overall, 64% of enrollees received a colonoscopy and 36% received a fecal immunochemical test/fecal occult blood test. Male (OR=1.21, 95% CI=1.08, 1.37) compared with female enrollees and those with 4-6 (OR=1.57, 95% CI=1.15, 2.15), 7-10 (OR=2.23, 95% CI=1.64, 3.03), and ≥11 (OR=1.79, 95% CI=1.22, 2.65) primary care visits compared with 0-3 visits had higher odds of colonoscopy screening. Non-White, non-Hispanic enrollees (OR=0.71, 95% CI=0.58, 0.87) compared with White, non-Hispanics Whites had lower odds of colonoscopy screening. Practices with an endoscopy facility within their ZIP code (OR=1.50, 95% CI=1.08, 2.08) compared with practices without a nearby endoscopy facility had higher odds of colonoscopy screening. CONCLUSIONS: Among newly age-eligible Medicaid enrollees who received colorectal cancer screening, non-White, non-Hispanic individuals were less likely and male enrollees and those with ≥4 primary care visits were more likely to undergo colonoscopy versus fecal immunochemical test/fecal occult blood test. Colonoscopy also was the more common modality among adults whose primary care clinic had an endoscopy facility in the same ZIP code. Future research is needed to fully understand patient, provider, and practice preferences regarding screening modality.
Authors: Stacey A Fedewa; Douglas A Corley; Christopher D Jensen; Wei Zhao; Michael Goodman; Ahmedin Jemal; Kevin C Ward; Theodore R Levin; Chyke A Doubeni Journal: Am J Prev Med Date: 2017-04-17 Impact factor: 5.043
Authors: Amanda F Petrik; Thuy Le; Erin Keast; Jennifer Rivelli; Keshia Bigler; Beverly Green; William M Vollmer; Gloria Coronado Journal: J Community Health Date: 2018-02
Authors: K John McConnell; Anna Marie Chang; Deborah J Cohen; Neal Wallace; Michael E Chernew; Glenn Kautz; Dennis McCarty; Bentson McFarland; Bill Wright; Jeanene Smith Journal: Healthc (Amst) Date: 2014-09
Authors: John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward Journal: Arch Intern Med Date: 2012-04-09
Authors: Gloria D Coronado; Amanda F Petrik; William M Vollmer; Stephen H Taplin; Erin M Keast; Scott Fields; Beverly B Green Journal: JAMA Intern Med Date: 2018-09-01 Impact factor: 21.873
Authors: Paul Ritvo; Ronald E Myers; Lawrence Paszat; Mardie Serenity; Daniel F Perez; Linda Rabeneck Journal: BMC Public Health Date: 2013-05-24 Impact factor: 3.295
Authors: Cynthia M Mojica; Rose Gunn; Robyn Pham; Edward J Miech; Ann Romer; Stephanie Renfro; Khaya D Clark; Melinda M Davis Journal: BMC Cancer Date: 2022-01-25 Impact factor: 4.430